The Chimeric Antigen Receptor (CAR) T-Cell Therapy market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Chimeric Antigen Receptor (CAR) T-Cell Therapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Chimeric Antigen Receptor (CAR) T-Cell Therapy market.
Key players in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market covered in Chapter 2 and Chapter 6:
Puretech Health
F. Hoffman La Roche AG
Servier Laboratories
Eureka Therapeutics Inc.
Protheragen Inc.
Takeda Pharmaceuticals
Celyad SA
Bellicum Phamaceuticals
iCell Gene Therapeutics
Novartis AG
Shire Pharmaceuticals Inc.
Formula Pharmaceuticals Inc.
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Avacta Life Sciences Ltd.
Celgene Corp.
Medimmune Llc/Astrazeneca
Transgene SA
Juno Therapeutics Inc. (A Celgene Company)
Cellectis
Gilead Sciences
Editas Medicine Inc.
Bluebird Bio
Mustang Bio Inc.
Noile-Immune Biotech
Amgen
In Chapter 8 and Chapter 10.3, based on types, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2029 is primarily split into:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
In Chapter 9 and Chapter 10.4, based on applications, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2029 covers:
Children
Adult
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy market, containing global revenue and CAGR. The forecast and analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Chimeric Antigen Receptor (CAR) T-Cell Therapy. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Chimeric Antigen Receptor (CAR) T-Cell Therapy industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Chimeric Antigen Receptor (CAR) T-Cell Therapy industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Chimeric Antigen Receptor (CAR) T-Cell Therapy in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Chimeric Antigen Receptor (CAR) T-Cell Therapy market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Chimeric Antigen Receptor (CAR) T-Cell Therapy, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Chimeric Antigen Receptor (CAR) T-Cell Therapy market, including the global sales and revenue forecast, regional forecast. It also foresees the Chimeric Antigen Receptor (CAR) T-Cell Therapy market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Type
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Acute Lymphoblastic Leukemia (ALL)
1.2.3 The Market Profile of Advanced Lymphomas
1.2.4 The Market Profile of Others
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Application
1.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Children
1.3.3 The Market Profile of Adult
1.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, Region Wise (2017-2022)
1.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.2 UK Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.5 Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.3.7 Poland Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.8 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2022)
1.5 Global Market Size of Chimeric Antigen Receptor (CAR) T-Cell Therapy (2017-2029)
1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Status and Outlook (2017-2029)
1.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Status and Outlook (2017-2029)
2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Landscape by Player
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Share by Player (2017-2022)
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Player (2017-2022)
2.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Average Price by Player (2017-2022)
2.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
2.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Situation and Trends
2.6.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Rate
2.6.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Upstream and Downstream Analysis
3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Chimeric Antigen Receptor (CAR) T-Cell Therapy Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Chimeric Antigen Receptor (CAR) T-Cell Therapy
5.3.2 Increased Demand in Emerging Markets
5.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Puretech Health
6.1.1 Puretech Health Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.1.3 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.1.4 Puretech Health Business Overview
6.2 F. Hoffman La Roche AG
6.2.1 F. Hoffman La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.2.3 F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.2.4 F. Hoffman La Roche AG Business Overview
6.3 Servier Laboratories
6.3.1 Servier Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.3.3 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.3.4 Servier Laboratories Business Overview
6.4 Eureka Therapeutics Inc.
6.4.1 Eureka Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.4.3 Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.4.4 Eureka Therapeutics Inc. Business Overview
6.5 Protheragen Inc.
6.5.1 Protheragen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.5.3 Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.5.4 Protheragen Inc. Business Overview
6.6 Takeda Pharmaceuticals
6.6.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.6.3 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.6.4 Takeda Pharmaceuticals Business Overview
6.7 Celyad SA
6.7.1 Celyad SA Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.7.3 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.7.4 Celyad SA Business Overview
6.8 Bellicum Phamaceuticals
6.8.1 Bellicum Phamaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.8.3 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.8.4 Bellicum Phamaceuticals Business Overview
6.9 iCell Gene Therapeutics
6.9.1 iCell Gene Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.9.3 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.9.4 iCell Gene Therapeutics Business Overview
6.10 Novartis AG
6.10.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.10.3 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.10.4 Novartis AG Business Overview
6.11 Shire Pharmaceuticals Inc.
6.11.1 Shire Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.11.3 Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.11.4 Shire Pharmaceuticals Inc. Business Overview
6.12 Formula Pharmaceuticals Inc.
6.12.1 Formula Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.12.3 Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.12.4 Formula Pharmaceuticals Inc. Business Overview
6.13 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
6.13.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Basic Information, Manufacturing Base, Sales Area and Competitors
6.13.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.13.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.13.4 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Business Overview
6.14 Avacta Life Sciences Ltd.
6.14.1 Avacta Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
6.14.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.14.3 Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.14.4 Avacta Life Sciences Ltd. Business Overview
6.15 Celgene Corp.
6.15.1 Celgene Corp. Basic Information, Manufacturing Base, Sales Area and Competitors
6.15.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.15.3 Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.15.4 Celgene Corp. Business Overview
6.16 Medimmune Llc/Astrazeneca
6.16.1 Medimmune Llc/Astrazeneca Basic Information, Manufacturing Base, Sales Area and Competitors
6.16.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.16.3 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.16.4 Medimmune Llc/Astrazeneca Business Overview
6.17 Transgene SA
6.17.1 Transgene SA Basic Information, Manufacturing Base, Sales Area and Competitors
6.17.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.17.3 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.17.4 Transgene SA Business Overview
6.18 Juno Therapeutics Inc. (A Celgene Company)
6.18.1 Juno Therapeutics Inc. (A Celgene Company) Basic Information, Manufacturing Base, Sales Area and Competitors
6.18.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.18.3 Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.18.4 Juno Therapeutics Inc. (A Celgene Company) Business Overview
6.19 Cellectis
6.19.1 Cellectis Basic Information, Manufacturing Base, Sales Area and Competitors
6.19.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.19.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.19.4 Cellectis Business Overview
6.20 Gilead Sciences
6.20.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
6.20.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.20.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.20.4 Gilead Sciences Business Overview
6.21 Editas Medicine Inc.
6.21.1 Editas Medicine Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.21.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.21.3 Editas Medicine Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.21.4 Editas Medicine Inc. Business Overview
6.22 Bluebird Bio
6.22.1 Bluebird Bio Basic Information, Manufacturing Base, Sales Area and Competitors
6.22.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.22.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.22.4 Bluebird Bio Business Overview
6.23 Mustang Bio Inc.
6.23.1 Mustang Bio Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.23.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.23.3 Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.23.4 Mustang Bio Inc. Business Overview
6.24 Noile-Immune Biotech
6.24.1 Noile-Immune Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.24.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.24.3 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.24.4 Noile-Immune Biotech Business Overview
6.25 Amgen
6.25.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
6.25.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
6.25.3 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance (2017-2022)
6.25.4 Amgen Business Overview
7 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Region Wise (2017-2022)
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share, Region Wise (2017-2022)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.5 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.7 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.8 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.9 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.10 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
7.11 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
8 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share by Type (2017-2022)
8.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Type (2017-2022)
8.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
8.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Growth Rate by Type (2017-2022)
8.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
8.4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Growth Rate of Advanced Lymphomas (2017-2022)
8.4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Growth Rate of Others (2017-2022)
9 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Application
9.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2017-2022)
9.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Growth Rate of Children (2017-2022)
9.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Growth Rate of Adult (2017-2022)
10 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast (2022-2029)
10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue Forecast (2022-2029)
10.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price and Trend Forecast (2022-2029)
10.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Revenue Forecast (2022-2029)
10.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Forecast by Application (2022-2029)
10.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Under COVID-19
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Data Source
List of Tables and Figures
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Picture
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and CAGR (%) Comparison by Type
Table Profile of Acute Lymphoblastic Leukemia (ALL)
Table Profile of Advanced Lymphomas
Table Profile of Others
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Children
Table Profile of Adult
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure UK Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure France Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Poland Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Malaysia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Singapore Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Philippines Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Indonesia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Thailand Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Vietnam Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Colombia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Egypt Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure South Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Nigeria Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Status and Outlook (2017-2029)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Player (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Player (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Player in 2021
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Base Distribution and Sales Area by Player
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
Table Puretech Health Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Puretech Health Revenue and Growth Rate
Figure Puretech Health Revenue Market Share 2017-2022
Table F. Hoffman La Roche AG Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure F. Hoffman La Roche AG Revenue and Growth Rate
Figure F. Hoffman La Roche AG Revenue Market Share 2017-2022
Table Servier Laboratories Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Servier Laboratories Revenue and Growth Rate
Figure Servier Laboratories Revenue Market Share 2017-2022
Table Eureka Therapeutics Inc. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Eureka Therapeutics Inc. Revenue and Growth Rate
Figure Eureka Therapeutics Inc. Revenue Market Share 2017-2022
Table Protheragen Inc. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Protheragen Inc. Revenue and Growth Rate
Figure Protheragen Inc. Revenue Market Share 2017-2022
Table Takeda Pharmaceuticals Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceuticals Revenue and Growth Rate
Figure Takeda Pharmaceuticals Revenue Market Share 2017-2022
Table Celyad SA Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Celyad SA Revenue and Growth Rate
Figure Celyad SA Revenue Market Share 2017-2022
Table Bellicum Phamaceuticals Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Bellicum Phamaceuticals Revenue and Growth Rate
Figure Bellicum Phamaceuticals Revenue Market Share 2017-2022
Table iCell Gene Therapeutics Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure iCell Gene Therapeutics Revenue and Growth Rate
Figure iCell Gene Therapeutics Revenue Market Share 2017-2022
Table Novartis AG Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2017-2022
Table Shire Pharmaceuticals Inc. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Shire Pharmaceuticals Inc. Revenue and Growth Rate
Figure Shire Pharmaceuticals Inc. Revenue Market Share 2017-2022
Table Formula Pharmaceuticals Inc. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Formula Pharmaceuticals Inc. Revenue and Growth Rate
Figure Formula Pharmaceuticals Inc. Revenue Market Share 2017-2022
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Revenue and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Revenue Market Share 2017-2022
Table Avacta Life Sciences Ltd. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Avacta Life Sciences Ltd. Revenue and Growth Rate
Figure Avacta Life Sciences Ltd. Revenue Market Share 2017-2022
Table Celgene Corp. Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Celgene Corp. Revenue and Growth Rate
Figure Celgene Corp. Revenue Market Share 2017-2022
Table Medimmune Llc/Astrazeneca Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Medimmune Llc/Astrazeneca Revenue and Growth Rate
Figure Medimmune Llc/Astrazeneca Revenue Market Share 2017-2022
Table Transgene SA Profile
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
Table Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Transgene SA Revenue and Growth Rate
Fi
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)